#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Polymyositis Nasopharyngeal cancer Idiopathic intracranial hypertension Mixed-type liposarcoma C3 glomerulopathy Pulmonary hypertension Non-small cell lung cancer Primary immunodeficiency syndrome Leiomyosarcoma Candida infection Advanced systemic mastocytosis Adult T-cell lymphoma/leukaemia refractory Familial hypertriglyceridaemia Atypical haemolytic uraemic syndrome Non-renal cell carcinoma of kidney More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Basic Information Sarcoidosis – Trials in Disease Advanced systemic mastocytosis – Treatment Idiopathic inflammatory myopathy Systemic sclerosis pulmonary – Trials in Disease Soft tissue sarcoma – Trials in Disease Netherton’s syndrome – Basic Information Mucous membrane pemphigoid – Treatment Marfan’s syndrome – Basic Information Factor VIII deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iberdomide Tramazoline Hydrochloride Ambrosia Artemisiifolia (302) Ivosidenib Mk-0616 Emapalumab Idelalisib Ketamine Hydrochloride ZILUCOPLAN Zongertinib Mk-6194 AUR200 GOVORESTAT Melatonin Methoxsalen L-Glutamic Acid Kd050 Fludarabine Phosphate Felis Domesticus (555) Infigratinib More therapies…

    Learn about Your Condition

    Neuroendocrine tumour Abortion threatened Multiple system atrophy Bone marrow disorder Micrographic skin surgery Hypochondroplasia Angiosarcoma metastatic Atopic keratoconjunctivitis Infertility male End stage renal disease Salivary gland cancer Round cell liposarcoma Sinus rhythm Haemofiltration Precocious puberty More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Treosulfan
    • Busulfan
    Italy

  • Study on the Safety of Eight Treg and Drug Combination for Patients with Chronic Kidney Failure Undergoing Transplant from a Living Donor

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Renal transplant
    Investigated Drugs:
    • Eight Treg
    • Methylprednisolone Hydrogen Succinate
    • Cetirizine Dihydrochloride
    France

  • Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Albumin Solution
    • Tinzaparin Sodium
    • Dalteparin Sodium
    Denmark Finland Iceland The Netherlands Sweden

  • Study of apomorphine and rifaximin for Parkinson’s disease patients with reduced levodopa effectiveness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Benserazide Hydrochloride
    • Domperidone
    • Rifaximin
    The Netherlands

  • Study of Itraconazole with Radiotherapy and Temozolomide for Patients with Newly Diagnosed Glioblastoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Itraconazole
    Germany

  • Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

    Recruiting

    3 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Tozorakimab
    Belgium Bulgaria Czechia Denmark France Germany +8
Previous Page
1 … 264 265 266 267 268 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!